Itepekimab (REGN-3500) is an IgG4 monoclonal antibody that targets interleukin-33 (IL-33). This antibody has demonstrated efficacy in reducing airway inflammation and associated tissue damage in early clinical trials. It holds therapeutic potential for a range of inflammatory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD). The specificity of Itepekimab for IL-33 makes it a promising candidate for further research and development in the management of these diseases.
Itepekimab (REGN-3500) is an IgG4 monoclonal antibody that targets interleukin-33 (IL-33). This antibody has demonstrated efficacy in reducing airway inflammation and associated tissue damage in early clinical trials. It holds therapeutic potential for a range of inflammatory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and atopic dermatitis (AD). The specificity of Itepekimab for IL-33 makes it a promising candidate for further research and development in the management of these diseases.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
